Navigation Links
Kiadis Pharma Receives IND Approval From FDA to Start Pivotal Clinical Trial With ATIR(TM) in the United States
Date:7/8/2010

AMSTERDAM, July 8 /PRNewswire/ -- Biopharmaceutical Company Kiadis Pharma announced today that it has received approval for its Investigational New Drug (IND) application with the US Food and Drug Administration (FDA) to start the pivotal clinical study for its product ATIR™ in the United States.  Kiadis Pharma is currently enrolling patients in a multinational, pivotal clinical study at hospitals in Europe and Canada.  With the approval of the IND, US hospitals will also participate in this study.

ATIR™ is designed for blood cancer patients in need of allogeneic bone marrow transplantation, who do not have a matched donor available.  ATIR™ allows a mismatched family member to act as donor, and is being developed to reduce Transplant Related Mortality without inducing Graft versus Host Disease (GvHD).

"We are very encouraged by this IND approval received from the FDA. We look forward to starting treatment of US patients in our ongoing multinational, pivotal clinical study, in which patients in Europe and Canada are already being treated," commented Manja Bouman, CEO of Kiadis Pharma.

ATIR™ has shown excellent clinical results in a phase I/II study in patients who received a haploidentical mismatched bone marrow transplantation from a family member donor.  The two year follow up data showed no Transplant Related Mortality (TRM) and overall survival of 70% in a group of high risk leukemia patients who received an efficacious dose of ATIR™.  These results compare favorably to outcomes of bone marrow transplantations from a ful
'/>"/>

SOURCE Kiadis Pharma
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine technology :

1. Kiadis Pharma Announces Promising Phase II Clinical Trial Results for Reviroc
2. Kiadis Pharma Announces Collaboration With the Julius Maximilians University of Wurzburg, Germany
3. Kiadis Pharma Announces Positive Clinical Results for ATIR(TM) in Mismatched Bone Marrow Transplantations
4. Kiadis Pharma Receives Two Orphan Drug Designations for Reviroc(TM) From the FDA
5. Thomson Scientific Publishes The Ones to Watch - A Quarterly Review of Phase Changes in the Pharmaceutical Pipeline
6. Auxilium Pharmaceuticals, Inc. Receives Clearance to Resume Clinical Trials for XIAFLEX(TM)
7. Vion Pharmaceuticals Completes Accrual of 85 Patients to its Pivotal Phase II Trial of Cloretazine(R) (VNP40101M) in Elderly AML
8. Solvay Pharmaceuticals, Inc. and Wyeth Pharmaceuticals Announce Receipt of an FDA Action Letter for Bifeprunox, an Investigational Treatment for Schizophrenia
9. Clinical Trial Effectiveness: How Pharmas & Biotechs Save Cost with Savvy Investigator Management
10. DOV Pharmaceutical, Inc. Announces Successful Phase Ib Results for DOV 21,947
11. Callisto Pharmaceuticals Opens Additional Sites for Phase II Clinical Trial of Atiprimod in Advanced Carcinoid Cancer Patients
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/28/2015)... Calif. , Aug. 28, 2015  CytomX Therapeutics, ... treatment of cancer, today announced the filing of a ... and Exchange Commission (SEC) relating to a proposed initial ... shares to be offered and the price range for ... to list its common stock under the symbol "CTMX" ...
(Date:8/28/2015)... Aug. 28, 2015 Research ... of the "Investigation Report on China,s Bevacizumab Market ... by Roche under the trade name of Avastin, bevacizumab ... In Feb.26, 2010, it was approved by CFDA to ... China all come from Roche ...
(Date:8/28/2015)... , Aug. 28, 2015  Today, in final recognition ... Contact Lens Health Week, 1-800 Contacts is sharing how ... that contact lens wearers who do not properly care ... for eye infections. Most contact lens ... but a clean lens case is sometimes overlooked.  When ...
Breaking Medicine Technology:CytomX Files Registration Statement for Proposed Initial Public Offering 2Investigation Report on China's Bevacizumab Market 2015-2019 21-800 Contacts Shares Tips on How to Clean Lens Cases 2
... ORANGE COUNTY, Calif., Feb. 15, 2011  Beckman Coulter, Inc. (NYSE: ... of directors unanimously recommends that Beckman Coulter,s stockholders tender ... ) at the previously announced price of $83.50 per ... (Logo:   http://photos.prnewswire.com/prnh/20031202/BECLOGO ) The transaction is ...
... Healthcare Solutions, Inc. (Allscripts) (Nasdaq: MDRX ) today ... 31, 2010. Fourth Quarter Highlights: ... legacy Allscripts bookings of $140.4 million and legacy Eclipsys bookings ... sequentially over the third quarter of 2010 Legacy ...
Cached Medicine Technology:Beckman Coulter's Board of Directors Recommends Stockholders Accept Danaher's Cash Tender Offer 2Beckman Coulter's Board of Directors Recommends Stockholders Accept Danaher's Cash Tender Offer 3Allscripts Reports Fourth Quarter Results 2Allscripts Reports Fourth Quarter Results 3Allscripts Reports Fourth Quarter Results 4Allscripts Reports Fourth Quarter Results 5Allscripts Reports Fourth Quarter Results 6Allscripts Reports Fourth Quarter Results 7Allscripts Reports Fourth Quarter Results 8Allscripts Reports Fourth Quarter Results 9Allscripts Reports Fourth Quarter Results 10Allscripts Reports Fourth Quarter Results 11Allscripts Reports Fourth Quarter Results 12Allscripts Reports Fourth Quarter Results 13Allscripts Reports Fourth Quarter Results 14Allscripts Reports Fourth Quarter Results 15
(Date:8/30/2015)... ... August 31, 2015 , ... ChopChop Kids, the nonprofit ... , recently elected two new officers to serve on the organization’s Board of ... inspiring and teaching kids to cook real food with their families and help ...
(Date:8/30/2015)... ... ... Lizzie’s Lice Pickers , a company that offers professional live removal ... lice head checks for just $10, which is a significant discount from the normal ... lice treatment products. “With kids returning to school, it is very important to be ...
(Date:8/30/2015)... Boca Raton, Fl (PRWEB) , ... August 30, 2015 , ... ... and InHealth Media. Nutritional Products International and InHealth media is a global sales ... , “We are extremely pleased to continue our business relationship with Mr. Reid ...
(Date:8/29/2015)... ... , ... Rio Salado College President Chris Bustamante announced on Aug. ... Strategic Initiatives and Information Services. O’Shea, who has served Rio Salado for the last ... impact through innovative technologies and strategies. , “I am very proud to be able ...
(Date:8/29/2015)... ... August 29, 2015 , ... ... two inventors from Miller Place, N.Y. "I specialize in manual therapy, and my ... addition, it can be used for additional muscle dysfunction throughout the body." , ...
Breaking Medicine News(10 mins):Health News:ChopChop Kids Appoints New Chair and Vice-Chair to Board of Directors 2Health News:ChopChop Kids Appoints New Chair and Vice-Chair to Board of Directors 3Health News:Lizzie’s Lice Pickers Announces Back to School Head Check Special and Discounted Lice Treatment Products 2Health News:Nutrition Guru Continues Relationship With Renowned Health and Wellness Company 2Health News:Rio Salado College Appoints New Vice President of Strategic Initiatives and Information Services 2Health News:Inventors and InventHelp Clients Develops Tension Reliever (LGI-1951) 2
... bird flu virus has been detected in Asia, the British ... for any evidence of bird flu. ,The death ... and parks will be brought to the notice of the ... 1,200 sq Kms area will be brought under surveillance. ...
... AMA President, Dr Mukesh Haikerwal, today welcomed the Stern ... devastating health //impact of climate change on the world’s ... now. ,Commissioned by the UK Government and prepared ... the report has been described by British Prime Minister, ...
... the first online game in Kiswahili, with the aim of ... game is named as "What would you do?" (Ungefanyaje?) and ... importance of prevention and testing is understood. ,According ... not know how to protect themselves from Aids. ...
... medical treatment to correct the malady, a media report said ... problems affected 50 percent of men over 50 in China, ... said. ,But Andrew Yip Wai-chun, honorary consultant at ... Hospitals, who released details of the study, said just 36 ...
... in AIDS/HIV cases, and have begun to act fast to ... of gay citizens, The Chinese government has opened up the ... be administered jointly by the Disease Prevention and Control centre ... a response to the growing body of concern among HIV/AIDS ...
... death due to bird flu, according to the recent communiqué ... Abdel Rahman Shaheen said "It is the seventh death due ... domestic poultry, and was taken to hospital on October 4 ... in the line of fire, being in the path of ...
Cached Medicine News:Health News:A Timely Reminder Of Devastating Health Impact Of Climate Change 2
Intended for the quantitative determination of gammaglutamyl transferase activity in serum or plasma. Single vial, dry powder reagent. Readily soluble at room temperature. Reaction: Kinetic. Waveleng...
Intended for the quantitative determination of calcium in serum. Endpoint Reaction. Reaction complete within one minute, color developed is stable for 30 minutes. Wavelength: 570 nm. Linearity: 16 mg...
For the quantitative determination of alanine aminotransferase in serum used in routine examination and monitoring of therapy and relapses....
For the quantitative determination of Alanine Aminotransferase in serum. Optimized IFCC without P-5'-P, Linearity: 500 IU/L at 37 C. Liquid Working Reagent prepared with simple 1:9 dilution....
Medicine Products: